{
    "title": "Buyout fund Ardian makes $1.2 bln swoop on Italy's Biofarma Group - sources",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10407815/Buyout-fund-Ardian-makes-1-2-bln-swoop-Italys-Biofarma-Group--sources.html",
    "date": "2022-01-16",
    "keywords": [
        "firm",
        "biofarma",
        "deal",
        "bridge",
        "pamela",
        "group",
        "year",
        "transaction",
        "market",
        "food",
        "revenue",
        "manufacturing",
        "investment",
        "purchase",
        "bc",
        "equity",
        "ardian",
        "drug",
        "knowledge",
        "matter",
        "monday",
        "supplement",
        "industry",
        "immunity",
        "comment",
        "executive",
        "maurizio",
        "castorina",
        "euros",
        "rampd",
        "labs",
        "compound",
        "growth",
        "rate",
        "cagr",
        "view",
        "research",
        "demand",
        "driving",
        "factor",
        "world",
        "contract",
        "development",
        "cdmo",
        "player",
        "recipharm",
        "bank",
        "nomura",
        "adviser",
        "financing",
        "provider",
        "capital",
        "ethica",
        "owner",
        "offer",
        "buyout",
        "fund",
        "condition",
        "anonymity",
        "exit",
        "investor",
        "marco",
        "pinciroli",
        "control",
        "portfolio",
        "company",
        "workforce",
        "series",
        "majority",
        "stake",
        "division",
        "giellepi",
        "december",
        "sitholematarise"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}